BACKGROUND AND PURPOSE: A crucial role for the GABAB receptor in depression was proposed several years ago, but there are limited data to support this proposition. Therefore we decided to investigate the antidepressant-like activity of the selective GABAB receptor antagonists CGP 36742 and CGP 51176, and a selective agonist CGP 44532 in models of depression in rats and mice. EXPERIMENTAL APPROACH: Effects of CGP 36742 and CGP 51176 as well as the agonist CGP 44532 were assessed in the forced swim test in mice. Both antagonists were also investigated in an olfactory bulbectomy (OB) model of depression in rats, while CGP 51176 was also investigated in the chronic mild stress (CMS) rat model of depression. The density of GABAB receptors in the mouse hippocampus after chronic administration of CGP 51176 was also investigated. KEY RESULTS: The GABAB receptor antagonists CGP 36742 and CGP 51176 exhibited antidepressant-like activity in the forced swim test in mice. The GABAB receptor agonist CGP 44532 was not effective in this test, however, it counteracted the antidepressant-like effects of CGP 51176. The antagonists CGP 36742 and CGP 51176 were effective in an OB model of depression in rats. CGP 51176 was also effective in the CMS rat model of depression. Administration of CGP 51176 increased the density of GABAB receptors in the mouse hippocampus. CONCLUSIONS AND IMPLICATIONS: These data suggest that selective GABAB receptor antagonists may be useful in treatment of depression, and support an important role for GABA-ergic transmission in this disorder.
BACKGROUND AND PURPOSE: A crucial role for the GABAB receptor in depression was proposed several years ago, but there are limited data to support this proposition. Therefore we decided to investigate the antidepressant-like activity of the selective GABAB receptor antagonists CGP 36742 and CGP 51176, and a selective agonist CGP 44532 in models of depression in rats and mice. EXPERIMENTAL APPROACH: Effects of CGP 36742 and CGP 51176 as well as the agonist CGP 44532 were assessed in the forced swim test in mice. Both antagonists were also investigated in an olfactory bulbectomy (OB) model of depression in rats, while CGP 51176 was also investigated in the chronic mild stress (CMS) rat model of depression. The density of GABAB receptors in the mouse hippocampus after chronic administration of CGP 51176 was also investigated. KEY RESULTS: The GABAB receptor antagonists CGP 36742 and CGP 51176 exhibited antidepressant-like activity in the forced swim test in mice. The GABAB receptor agonist CGP 44532 was not effective in this test, however, it counteracted the antidepressant-like effects of CGP 51176. The antagonists CGP 36742 and CGP 51176 were effective in an OB model of depression in rats. CGP 51176 was also effective in the CMSrat model of depression. Administration of CGP 51176 increased the density of GABAB receptors in the mouse hippocampus. CONCLUSIONS AND IMPLICATIONS: These data suggest that selective GABAB receptor antagonists may be useful in treatment of depression, and support an important role for GABA-ergic transmission in this disorder.
Authors: Cedric Mombereau; Klemens Kaupmann; Martin Gassmann; Bernhard Bettler; Herman van der Putten; John F Cryan Journal: Neuroreport Date: 2005-02-28 Impact factor: 1.837
Authors: A Pilc; A Kłodzińska; P Brański; G Nowak; A Pałucha; B Szewczyk; E Tatarczyńska; E Chojnacka-Wójcik; J M Wierońska Journal: Neuropharmacology Date: 2002-08 Impact factor: 5.250
Authors: Seb J Thuault; Jon T Brown; Steven A Sheardown; Sabine Jourdain; Benjamin Fairfax; Jonathan P Spencer; Sophie Restituito; Josephine H L Nation; Stephanie Topps; Andrew D Medhurst; Andrew D Randall; Andres Couve; Stephen J Moss; Graham L Collingridge; Menelas N Pangalos; Ceri H Davies; Andrew R Calver Journal: Biochem Pharmacol Date: 2004-10-15 Impact factor: 5.858
Authors: Laura H Jacobson; Daniel Hoyer; Dominique Fehlmann; Bernhard Bettler; Klemens Kaupmann; John F Cryan Journal: Psychopharmacology (Berl) Date: 2017-01-09 Impact factor: 4.530
Authors: Benjamin Spurny; Rene Seiger; Philipp Moser; Thomas Vanicek; Murray B Reed; Eva Heckova; Paul Michenthaler; Alim Basaran; Gregor Gryglewski; Manfred Klöbl; Siegfried Trattnig; Siegfried Kasper; Wolfgang Bogner; Rupert Lanzenberger Journal: Neuroimage Date: 2019-10-10 Impact factor: 6.556
Authors: Olivia F O'Leary; Daniela Felice; Stefano Galimberti; Hélène M Savignac; Javier A Bravo; Tadhg Crowley; Malika El Yacoubi; Jean-Marie Vaugeois; Martin Gassmann; Bernhard Bettler; Timothy G Dinan; John F Cryan Journal: Proc Natl Acad Sci U S A Date: 2014-10-06 Impact factor: 11.205
Authors: Hyo Jung Kang; David H Adams; Arthur Simen; Birgitte B Simen; Grazyna Rajkowska; Craig A Stockmeier; James C Overholser; Herbert Y Meltzer; George J Jurjus; Lisa C Konick; Samuel S Newton; Ronald S Duman Journal: J Neurosci Date: 2007-11-28 Impact factor: 6.167